REDRAWING THE PHARMA BUSINESS MODEL: DRUG PRICING AND MARKET ACCESS UNDER NIGERIA’S NHIA REFORM ERA

by Stren & Blan Partners | Nov 24, 2025 | Health and Pharmaceutical, Insight

Nigeria’s shift from a voluntary health insurance scheme to a mandatory national system under the National Health Insurance Authority (NHIA) Act represents one of the most consequential transformations in the country’s healthcare financing landscape. For decades, the...

THE HEALTH AND PHARMACEUTICAL SECTOR QUARTERLY ROUND-UP FOR Q3 2025

by Stren & Blan Partners | Oct 14, 2025 | Health and Pharmaceutical, Insight

The third quarter of 2025 was a notable period in Nigeria’s health and pharmaceutical trajectory, characterised by a sequence of reforms designed to enhance structural efficiency and restore investor confidence. Central to this evolving transformation was the...

FREQUENTLY ASKED QUESTIONS ON PUBLIC-PRIVATE PARTNERSHIP IN THE HEALTH AND PHARMACEUTICAL SECTOR

by Stren & Blan Partners | Sep 18, 2025 | Health and Pharmaceutical, Insight

Public-Private Partnerships (PPPs) are becoming an increasingly important mechanism for financing, building, and operating healthcare infrastructure and services in Nigeria. With government budgets stretched and demand for quality healthcare rising, PPPs offer a way...

REGULATING TELEMEDICINE IN NIGERIA’S PHARMACEUTICAL MARKET: BALANCING PRICE CONTROL, COMPETITION, AND ACCESSIBILITY.

by Stren & Blan Partners | Sep 4, 2025 | Health and Pharmaceutical, Insight

The advent of telemedicine has redefined healthcare delivery globally, and Nigeria is no exception. Telemedicine emerged as a result of technological advancements and its increasing integration into daily life. It involves the use of telecommunications and digital...

HEALTH AND PHARMACEUTICAL SECTOR QUARTERLY INSIGHTS

by Stren & Blan Partners | Jul 21, 2025 | Health and Pharmaceutical, Insight

The second quarter of 2025 marked a dynamic phase in Nigeria’s health sector, defined by reforms in pharmaceutical manufacturing, international collaboration, and stringent regulatory enforcement. The Federal Government announced a two-year exemption on import duty...

NAVIGATING AI REGULATION AND INNOVATION IN NIGERIA’S HEALTH AND PHARMACEUTICAL SECTOR

by Stren & Blan Partners | May 15, 2025 | Health and Pharmaceutical, Insight

Artificial intelligence (AI) is reshaping the global healthcare landscape, enhancing efficiency, diagnostics, and patient outcomes. With Nigeria witnessing a surge in AI-driven healthcare innovations, businesses must navigate an evolving regulatory framework to...